Celcuity (CELC) Capital Expenditures Growth (3y) (2019 - 2025)
Celcuity (CELC) Capital Expenditures Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
-22.08% |
| Date | Value |
|---|
| Dec 31, 2025 |
-22.08% |
| Sep 30, 2025 |
100.12% |
| Jun 30, 2025 |
19.27% |
| Mar 31, 2025 |
72.77% |
| Dec 31, 2024 |
65.43% |
| Sep 30, 2024 |
53.64% |
| Jun 30, 2024 |
33.38% |
| Mar 31, 2024 |
42.77% |
| Dec 31, 2023 |
33.07% |
| Sep 30, 2023 |
81.34% |
| Jun 30, 2023 |
-38.61% |
| Mar 31, 2023 |
-46.49% |
| Dec 31, 2022 |
82.15% |
| Sep 30, 2022 |
27.48% |
| Jun 30, 2022 |
28.04% |
| Mar 31, 2022 |
-37.49% |
| Dec 31, 2021 |
-59.28% |
| Sep 30, 2021 |
-49.65% |
| Jun 30, 2021 |
-45.65% |
| Mar 31, 2021 |
-46.70% |
